DBMZX
Price
$32.28
Change
+$0.65 (+2.06%)
Updated
Oct 20 closing price
Net Assets
1B
PMBCX
Price
$35.96
Change
+$0.32 (+0.90%)
Updated
Oct 20 closing price
Net Assets
31.93B
Interact to see
Advertisement

DBMZX vs PMBCX

Header iconDBMZX vs PMBCX Comparison
Open Charts DBMZX vs PMBCXBanner chart's image
BNY Mellon Sm/Md Cp Gr Z
Price$32.28
Change+$0.65 (+2.06%)
VolumeN/A
Net Assets1B
Principal MidCap C
Price$35.96
Change+$0.32 (+0.90%)
VolumeN/A
Net Assets31.93B
DBMZX vs PMBCX Comparison Chart in %
View a ticker or compare two or three
VS
DBMZX vs. PMBCX commentary
Oct 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DBMZX is a Hold and PMBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMBCX has more cash in the bank: 31.9B vs. DBMZX (1B). DBMZX (0.00) and PMBCX (0.00) have matching dividends . DBMZX was incepted earlier than PMBCX: DBMZX (8 years) vs PMBCX (19 years). PMBCX (1.75) is less costly to investors than DBMZX (0.88). DBMZX is a more actively managed with annual turnover of: 48.92 vs. PMBCX (10.50). DBMZX (1000) and PMBCX (1000) have matching initial minimum investment requirements. DBMZX annual gain was more profitable for investors over the last year : 18.29 vs. PMBCX (-3.88). PMBCX return over 5 years is better than : 28.94 vs. DBMZX (-10.93).
DBMZXPMBCXDBMZX / PMBCX
Total Expense Ratio0.831.7547%
Annual Report Gross Expense Ratio0.881.7550%
Fund Existence8 years19 years-
Gain YTD12.7092.450519%
Front LoadN/AN/A-
Min. Initial Investment10001000100%
Min. Initial Investment IRAN/AN/A-
Net Assets1B31.9B3%
Annual Yield % from dividends0.000.00-
Returns for 1 year18.29-3.88-472%
Returns for 3 years47.6745.94104%
Returns for 5 years-10.9328.94-38%
Returns for 10 years387.7574.22522%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
SLN7.190.69
+10.62%
Silence Therapeutics Plc
ENPH37.581.02
+2.79%
Enphase Energy
MGRX2.400.01
+0.42%
Mangoceuticals Inc
SCL45.57-0.05
-0.11%
Stepan Co
REGN576.77-1.28
-0.22%
Regeneron Pharmaceuticals